Comment on the report "limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease"

Int J Clin Pharmacol Ther. 2012 Sep;50(9):631-7; discussion 638. doi: 10.5414/cp201758a.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / administration & dosage*
  • Bronchodilator Agents / administration & dosage*
  • Drug Discovery / methods*
  • Drug Dosage Calculations*
  • Humans
  • Indans / administration & dosage*
  • Lung / drug effects*
  • Models, Theoretical*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Quinolones / administration & dosage*

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Indans
  • Quinolones
  • indacaterol